25例口腔鳞癌患者唾液代谢组学分析

doi:10.19439/j.sjos.2021.02.018

上海口腔医学 ›› 2021, Vol. 30 ›› Issue (2): 201-205.doi: 10.19439/j.sjos.2021.02.018

25例口腔鳞癌患者唾液代谢组学分析

薛佳艺¹, 朱晓燕², 危常磊³, 孙培³, 张慧³, 邓婧³

1.长治医学院附属和平医院口腔科,山西长治 046000;
2.山东大学齐鲁医院（青岛）口腔科,山东青岛 266000;
3.青岛大学附属医院口腔内科,山东青岛 266003

收稿日期:2020-03-09 修回日期:2020-06-16 出版日期:2021-04-25 发布日期:2021-05-11
通讯作者: 邓婧,E-mail：dengjing3333@126.com
作者简介:薛佳艺（1992-）,女,硕士,住院医师,E-mail：241829639@qq.com

Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia

XUE Jia-yi¹, ZHU Xiao-yan², WEI Chang-lei³, SUN Pei³, ZHANG Hui³, DENG Jing³

1. Department of Stomatology, Affiliated Peace Hospital of Changzhi Medical College. Changzhi 046000,Shanxi Province;
2. Department of Stomatology, Qilu Hospital of Shandong University (Qingdao). Qingdao 266000,Shandong Province;
3. Department of Oral Medicine, Affiliated Hospital of Qingdao University. Qingdao 266003, Shandong Province, China

Received:2020-03-09 Revised:2020-06-16 Online:2021-04-25 Published:2021-05-11

摘要/Abstract

摘要： 目的:用代谢组学方法检测并分析口腔鳞状细胞癌（oral squamous cell carcinoma,OSCC）是否有典型差异代谢物,探讨此方法用于临床诊断或筛查的可行性。方法:利用气相色谱-飞行时间质谱（GC-TOF-MS）代谢组学方法,对OSCC、口腔白斑（OLK）患者以及健康人的唾液标本进行分析,运用SIMCA软件对结果进行主成分分析和正交偏最小二乘法判别分析。结果:OSCC、OLK和健康对照组的代谢轮廓表现出显著差异（P<0.05）,3组之间存在的典型差异代谢物共有15种。进一步探讨其代谢通路,发现OSCC患者与OLK患者都存在不同程度的蛋白质代谢、能量代谢以及脂类代谢失衡现象;同时,还表现出三羧酸循环异常。结论:运用代谢组学方法可检测出OSCC、OLK与健康人之间存在着15种典型的差异代谢物,将有助于OSCC的早期筛查。

关键词: 口腔鳞癌, 口腔黏膜白斑, 代谢组学

Abstract: PURPOSE: The objective of this study was to detect and analyze the existence of differential metabolites from saliva of patients with oral squamous cell carcinoma(OSCC) by metabonomics method, and to evaluate its application value on clinical diagnosis or screening of OSCC. METHODS: The collected saliva samples for OSCC patients, oral leukoplakiac(OLK) patients who were pathologically diagnosed and met the inclusion criteria were analyzed using metabonomics methods (GC-TOF-MS). The results were analyzed by principal component analysis and orthogonal partial least squares discriminant analysis using SIMCA software. RESULTS: The metabolic profiles of OSCC, OLK and healthy control group showed significant differences (P<0.05). In total, 15 typical differential metabolites among the three groups were detected. Further study focusing on metabolic pathway revealed imbalance of protein, energy and lipid metabolism between OSCC and OLK patients. Abnormal tricarboxylic acid cycle was detected as well. CONCLUSIONS: Metabonomics methods is feasible for differential metabolites analysis,15 differential metabolites were detected in OSCC,OLK patients and healthy people. These findings will contribute to the early screening of oral squamous cell carcinoma .

Key words: Oral squamous cell carcinoma, Oral leukoplakia, Metabonomics

中图分类号:

R739.8

薛佳艺, 朱晓燕, 危常磊, 孙培, 张慧, 邓婧. 25例口腔鳞癌患者唾液代谢组学分析[J]. 上海口腔医学, 2021, 30(2): 201-205.

XUE Jia-yi, ZHU Xiao-yan, WEI Chang-lei, SUN Pei, ZHANG Hui, DENG Jing. Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia[J]. Shanghai Journal of Stomatology, 2021, 30(2): 201-205.

参考文献

[1] Amit M, Yen T, Liao C, et al.Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study[J]. Cancer, 2013,119(24): 4242-4248.
[2] Sakamoto Y, Matsushita Y, Yamada SI, et al.Risk factors of distant metastasis in patients with squamous cell carcinoma of the oral cavity[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 121(5): 474-480.
[3] Brouns E, Baart J, Bloemena E, et al.The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients[J]. Med Oral Patol Oral Cir Bucal, 2012, 18(1): e19-e26.
[4] Liu Y, Li Y, Fu Y, et al.Quantitative prediction of oral cancer risk in patients with oral leukoplakia[J]. Oncotarget, 2017, 8(28): 46057-46064.
[5] 王宇峰, 尚书, 周曾同, 等. 口腔白斑癌变率与癌变时间及其影响因素的回顾分析[J]. 上海口腔医学, 2011, 20(1): 65-71.
[6] Kim SJ, Kim SH, Kim JH, et al.Understanding metabolomics in biomedical research[J]. Endocrinol Metab, 2015, 31(1): 7-16.
[7] Gupta A, Gupta S, Mahdi A, et al.1H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma[J]. Clin Chim Acta, 2015, 441(1): 47-55.
[8] Ohshima M, Sugahara K, Kasahara K, et al.Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma[J]. Oncol Rep, 2017, 37(5): 2727-2734.
[9] Navazesh M.Methods for collecting saliva[J]. Ann N Y Acad Sci, 1993, 694(1):72-77.
[10] Martínez-Arranz, Ibon, Mayo R, Pérez-Cormenzana M, et al. Enhancing metabolomics research through data mining[J]. J Proteomics, 2015,127(Pt B): 275-288.
[11] Lubes G, Goodarzi M.GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers[J]. J Pharm Biomed Anal, 2018, 147: 313-322.
[12] Wang Q, Yu Q, Lin Q, et al.Emerging salivary biomarkers by mass spectrometry[J]. Clin Chim Acta, 2015, 438: 214-221.
[13] Koneru S, Tanikonda R.Salivaomics - a promising future in early diagnosis of dental diseases[J]. Dent Res J, 2014, 11(1): 11-15.
[14] Schwartz L, Supuran CT, Alfarouk KO.The warburg effect and the hallmarks of cancer[J]. Anticancer Agents Med Chem, 2017, 17(2): 164-170.
[15] Hui S, Ghergurovich JM, Morscher RJ, et al.Glucose feeds the TCA cycle via circulating lactate[J]. Nature, 2017, 551(7678): 115-118.
[16] Olsson B, Cox TF, Psarelli EE, et al.Relationship between serum concentrations of nitisinone and its effect on homogentisic acid and tyrosine in patients with alkaptonuria[J]. JIMD Rep, 2015, 24(1):21-27.
[17] Hussain SP, Harris CC.Inflammation and cancer: an ancient link with novel potentials[J]. Int J Cancer, 2007, 121(11): 2373-2380.
[18] Sheng H, Shao J, Washington MK, et al.Prostaglandin E2 increases growth and motility of colorectal carcinoma cells[J]. J Biological Chem, 2001, 276(21): 18075-18081.

25例口腔鳞癌患者唾液代谢组学分析

Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	董淋升, 唐进, 程维, 冉婧璇, 刘兆博, 李雅冬. IL-6和β-catenin在口腔鳞癌中的表达及预后价值[J]. 上海口腔医学, 2023, 32(3): 280-286.
[2]	胡小媛, 王宁, 张晓野, 杨茜, 高菲, 王成勤, 尚伟, 项锋钢, 冯元勇. Chemerin对口腔鳞癌中性粒细胞浸润的影响及机制探讨[J]. 上海口腔医学, 2023, 32(2): 158-165.
[3]	郭梦瑶, 李凯玉, 聂敏海, 刘旭倩. 上调Decorin对口腔鳞癌荷瘤裸鼠EGFR、C-Myc、p21表达的影响[J]. 上海口腔医学, 2023, 32(1): 40-46.
[4]	文旭涛, 马振, 张翀, 陶识丞, 陈兴金, 麦华明. 不同培养条件对CD133⁺原代口腔鳞癌细胞干性维持的影响[J]. 上海口腔医学, 2022, 31(4): 343-348.
[5]	秦志明, 揭伟萍, 池彦廷, 李宏锋, 李斌斌. 基于局部可变阈值的无监督定量Ki-67细胞增殖指数模型的初步建立[J]. 上海口腔医学, 2022, 31(3): 248-254.
[6]	买尔哈巴·买合木提, 拜婕, 如斯坦木·依米提, 姚志涛. 50例口腔鳞癌患者治疗过程中营养状况改变及影响因素分析[J]. 上海口腔医学, 2022, 31(2): 205-210.
[7]	谈亦然, 赵铜超, 琚梧桐, 钟来平. 长春新碱对口腔鳞癌中Stathmin调控作用的实验研究[J]. 上海口腔医学, 2022, 31(1): 1-5.
[8]	谢非, 秦星, 童桐, 蒋英英, 张建军. IGF2BP1在口腔鳞癌细胞耐药中的作用及机制探讨[J]. 上海口腔医学, 2021, 30(5): 456-461.
[9]	李蕾, 李晓东, 庄乾伟, 葛良玉, 李志萍, 顾倩平, 白玉婷, 孟箭. 超声热疗联合TPF化疗治疗19例老年晚期口腔鳞癌的疗效分析[J]. 上海口腔医学, 2021, 30(5): 543-547.
[10]	邵小钧, 朱乔, 刘有, 韩小东, 林小臻, 席庆. 咀嚼槟榔与口腔鳞癌的相关临床病理学因素分析[J]. 上海口腔医学, 2021, 30(3): 268-272.
[11]	王树斌, 秦帅华, 易雅群, 李新明. 216例口腔鳞癌患者术后心理困扰影响因素及放疗前、后生存质量评价[J]. 上海口腔医学, 2021, 30(1): 71-76.
[12]	傅宗云, 陶峰. MMP-14、ING4和HIF-1α在60例口腔鳞癌中的表达及临床意义[J]. 上海口腔医学, 2020, 29(6): 642-646.
[13]	李东源, 汤云居, 沈雪敏, 张蔚蒨, 熊屏. 口内超声成像在18例口腔非咀嚼黏膜白斑诊疗中的评价[J]. 上海口腔医学, 2020, 29(3): 275-280.
[14]	王学梅, 蒋勇. 双硫仑对口腔鳞癌细胞上皮-间充质转化的影响及机制探讨[J]. 上海口腔医学, 2020, 29(2): 138-145.
[15]	刘族志, 赵永兴, 林建能, 周国平. 双氢青蒿素对人口腔鳞癌细胞KBV200多药耐药的影响[J]. 上海口腔医学, 2019, 28(6): 586-590.